New Anxiety, Depression Common After Receiving Implantable Defibrillator
FRIDAY, May 14, 2021 -- New-onset anxiety and depression are common in the two years following the first-time placement of an implantable cardioverter defibrillator (ICD), according to a study presented at EHRA 2021, an online scientific congress hosted by the European Society of Cardiology.
Susanne Pedersen, Ph.D., from the University of Southern Denmark in Odense, and colleagues used data from 1,040 patients with a first-time ICD implant (June 2010 to April 2013) without clinical levels of anxiety and depression at the time of implant. During 24 months of follow-up, the incidence of new-onset anxiety and depression was examined.
The researchers found that the cumulative incidence of new-onset anxiety was 14.5 percent during follow-up, while the cumulative incidence of new-onset depression was 11.3 percent. There was an association observed between older age and a reduced risk for new-onset anxiety (hazard ratio [HR], 0.54), while being married (HR, 1.66), type D personality (HR, 2.50), and lower self-reported physical functioning (HR, 1.48) were associated with an increased risk for new-onset anxiety. For new-onset depression, older age (HR, 0.57) and higher self-reported physical functioning (HR, 0.46) were associated with a reduced risk, while smoking (HR, 2.13), type D personality (HR, 2.53), and lower self-reported physical functioning (HR, 1.64) were associated with an increased risk for new-onset depression.
"Most patients adapt well to living with an ICD," Pedersen said in a statement. "For others it completely changes their life, with worries about shocks from the device, body image, and livelihood."
© 2021 HealthDay. All rights reserved.
Posted May 2021
Read this next
FRIDAY, June 18, 2021 -- Parents with a baby in the neonatal intensive care unit (NICU) are at risk for depression, with fathers not seeing the same improvement in symptoms...
FRIDAY, June 18, 2021 -- The COVID-19 pandemic has contributed to worse mental health among adolescents, although there have been decreases in substance use, according to a study...
THURSDAY, June 17, 2021 -- Adults with past-year methamphetamine use have increased prevalence of mental illness, medical multimorbidity, and substance use disorder (SUD)...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.